화학공학소재연구정보센터
홈 로그인 로그아웃 연락처 사이트맵
Journal of Industrial and Engineering Chemistry, Vol.81, 367-374, January, 2020
DOI10.1016/j.jiec.2019.09.027  Export Citation
Compartment-restricted and rate-controlled dual drug delivery system using a biosilica-enveloped ferritin cage
Mi-Ran Ki1, 2, Jong Ki Kim1, Sung Ho Kim1, Thi Khoa My Nguyen1, Kyung Hee Kim1, and Seung Pil Pack1, †
  • 1Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-Ro, Sejong 30019, Republic of Korea
  • 2Institute of Industrial Technology, Korea University, 2511 Sejong-Ro, Sejong 30019, Republic of Korea
E-mail:
Combinational therapy has been exploited to enhance therapeutic efficiency against cancer by overcoming drug resistance and side-effects or by synergistic effects of multi drugs. However, the conventional co-delivery of combination regimens is often limited by the differences in physicochemical properties among different drugs. Here, to solve this problem, we demonstrated an advanced dual drug delivery system (dDDS) using a R5 peptide-fused ferritin (R5FT). Since the fused R5 can mediate biosilica deposition on the ferritin surface (SiO2/R5FT), we could load two types of molecules into the core inside (ferritin cage) and the shell outside (biosilica matrix), respectively. Doxorubicin (Dox) was loaded into the cage by the reassembly of R5FT to obtain R5FT(Dox), and then the monomeric red fluorescent protein (mRFP) or paclitaxel (PTX) was captured in situ by biosilica matrix formation to prepare SiO2(mRFP)/R5FT (Dox) or SiO2(PTX)/R5FT(Dox). The captured mRFP or PTX in the shell exhibited a short-term release, while Dox in the core showed a long-term sustained release. This dDDS with the additional release of PTX decreased the IC50 value of Dox by twofold compared to the use of only Dox in dDDS. The compartmentrestricted and rate-controlled dDDS using biosilica-enveloped ferritin cage can provide more efficient combinational drug therapies.
Keywords:Ferritin;Biosilica encapsulation;Dual drug delivery system;Doxorubicin;Paclitaxel
  1. Liang XJ, Chen C, Zhao Y, Wang PC, Methods Mol. Biol., 596, 467 (2010)
  2. Pento JT, Anticancer Res., 37, 5935 (2017)
  3. Minn AJ, Wherry EJ, Cell, 165, 272 (2016)
  4. Wu CF, Wang HM, Huang WK, Chang JW, Asia Pac. J. Clin. Oncol., 11, 314 (2015)
  5. Zhang C, Zhai S, Li X, Zhang Q, Wu L, Liu Y, Jiang C, Zhou H, Li F, Zhang S, Su G, Zhang B, Yan B, Cell Death Dis., 5, e1138 (2014)
  6. Han W, Shi L, Ren L, Zhou L, Li T, Qiao Y, Wang H, Signal Transduct. Target. Ther., 3, 16 (2018)
  7. Li JL, Cheng YJ, Zhang C, Cheng H, Feng J, Zhuo RX, Zeng X, Zhang XZ, ACS Appl. Mater. Interfaces, 10, 5287 (2018)
  8. Hu Q, Sun W, Wang C, Gu Z, Adv. Drug Deliv. Rev., 98, 19 (2016)
  9. Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY, Adv. Drug Deliv. Rev., 65, 1866 (2013)
  10. Aftab S, Shah A, Nadhman A, Kurbanoglu S, Ozkan SA, Dionysiou DD, Shukla SS, Aminabhavi TM, Int. J. Pharm., 540, 132 (2018)
  11. Bai L, Xie T, Hu Q, Deng C, Zheng R, Chen W, Sci. Nat., 102, 64 (2015)
  12. Uchida M, Kang S, Reichhardt C, Harlen K, Douglas T, Biochim. Biophys. Acta, 1800, 834 (2010)
  13. Zhen Z, Tang W, Chen H, Lin X, Todd T, Wang G, Cowger T, Chen X, Xie J, ACS Nano, 7, 4830 (2013)
  14. Zhen Z, Tang W, Todd T, Xie J, Expert Opin. Drug Deliv., 11(12), 1913 (2014)
  15. Wang Z, Gao H, Zhang Y, Liu G, Niu G, Chen X, Front. Chem. Sci. Eng., 11, 633 (2017)
  16. Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JRR, Rao SS, Kong WP, Wang LS, Nabel GJ, Nature, 499(7456), 102 (2013)
  17. Slowing I, Viveroescoto J, Wu C, Lin V, Adv. Drug Deliv. Rev., 60, 1278 (2008)
  18. Vallet-Regi M, Colilla M, Izquierdo-Barba I, Manzano M, Molecules, 23, 47 (2017)
  19. Maldonado M, Carmona C, Velasquez Z, Puig A, Cruzado A, Lopez A, Young CM, Limnol. Oceanogr., 50, 799 (2005)
  20. Kroger N, Deutzmann R, Sumper M, Science, 286, 1129 (1999)
  21. Shimizu K, Cha J, Stucky GD, Morse DE, Proc. Natl. Acad. Sci. U. S. A., 95, 6234 (1998)
  22. Foo CWP, Huang J, Kaplan DL, Trends Biotechnol., 22, 577 (2004)
  23. Lechner CC, Becker CF, Mar. Drugs, 13, 5297 (2015)
  24. Arakaki A, Shimizu K, Oda M, Sakamoto T, Nishimura T, Kato T, Org. Biomol. Chem., 13, 974 (2015)
  25. Baio JE, Zane A, Jaeger V, Roehrich AM, Lutz H, Pfaendtner J, Drobny GP, Weidner T, J. Am. Chem. Soc., 136(43), 15134 (2014)
  26. Ki MR, Yeo KB, Pack SP, Bioprocess Biosyst. Eng., 36, 643 (2013)
  27. Ki MR, Jang EK, Pack SP, Process Biochem., 49(1), 95 (2014)
  28. Min KH, Son RG, Ki MR, Choi YS, Pack SP, Chemosphere, 143, 128 (2016)
  29. Ryu YH, Yeo KB, Ki MR, Kim YJ, Pack SP, Biochem. Eng. J., 105, 144 (2016)
  30. Yeo KB, Ki MR, Park KS, Pack SP, Process Biochem., 58, 193 (2017)
  31. Park KS, Ki MR, Yeo KB, Choi JH, Pack SP, Biochem. Eng. J., 128, 12 (2017)
  32. Jo YK, Choi BH, Kim CS, Cha HJ, Adv. Mater., 29, 170490 (2017)
  33. Abdelhamid MAA, Yeo KB, Ki MR, Pack SP, Int. J. Biol. Macromol., 125, 1175 (2019)
  34. Ki MR, Nguyen TKM, Jun HS, Pack SP, Process Biochem., 68, 182 (2018)
  35. Lechner CC, Becker CFW, Bioorg. Med. Chem., 21, 3533 (2013)
  36. Tacar O, Sriamornsak P, Dass CR, J. Pharm. Pharmacol., 65, 157 (2013)
  37. Weaver BA, Bement W, Mol. Biol. Cell, 25, 2677 (2014)
  38. Cho KJ, Shin HJ, Lee JH, Kim KJ, Park SS, Lee Y, Lee C, Park SS, Kim KH, J. Mol. Biol., 390, 83 (2009)
  39. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA, Int. J. Pharm., 15, 25 (1983)
  40. Dash S, Murthy PN, Nath L, Chowdhury P, Acta Pol. Pharm., 67, 217 (2010)
  41. Belton DJ, Deschaume O, Perry CC, FEBS J., 279, 1710 (2012)
  42. Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, Che E, Hu L, Zhang Q, Jiang T, Wang S, Nanomedicine, 11, 313 (2016)
  43. Zhou Y, Quan G, Wu Q, Zhang X, Niu B, Wu B, Huang Y, Pan X, Wu C, Acta Pharm. Sin. B, 8, 165 (2018)
  44. Luckarift HR, Spain JC, Naik RR, Stone MO, Nat. Biotechnol., 22, 211 (2004)
  45. Lechner CC, Becker CF, Bioorg. Med. Chem., 21, 3533 (2013)
  46. Mendez A, Bosch E, Roses M, Neue UD, J. Chromatogr. A, 986, 33 (2003)
  47. Sanli S, Altun Y, Guven G, J. Chem. Eng. Data, 59(12), 4015 (2014)
  48. Liu Y, Wang W, Yang J, Zhou C, Sun J, Asian J. Pharm. Sci., 8, 159 (2013)
  49. Jiang B, Zhang R, Zhang J, Hou Y, Chen X, Zhou M, Tian X, Hao C, Fan K, Yan X, Theranostics, 9, 2167 (2019)
  50. Parent M, Baradari H, Champion E, Damia C, Viana-Trecant M, J. Control. Release, 252, 1 (2017)
  51. Yu M, Zhou K, Li Z, Zhang D, Mater. Sci. Eng. C-Biomimetic Supramol. Syst., 45, 306 (2014)
  52. Cychosz KA, Thommes M, Engineering, 4, 559 (2018)
  53. Nguyen TKM, Kim MR, Lee CS, Pack SP, J. Ind. Eng. Chem., 73, 198 (2019)
  54. Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH, J. Clin. Oncol., 16, 2445 (1998)
  55. Harries M, Ellis P, Harper P, J. Clin. Oncol., 23, 7768 (2005)
  56. Lee J, Lee SC, Acharya G, Chang CJ, Park K, Pharm Res., 20, 1022 (2003)
  57. Jia L, Shen J, Li Z, Zhang D, Zhang Q, Liu G, Zheng D, Tian X, Int. J. Pharm., 445, 12 (2013)
  58. Lu J, Liong M, Sherman S, Xia T, Kovochich M, Nel AE, Zink JI, Tamanoi F, anobiotechnology, 3, 89 (2007)
  59. Feng T, Tian H, Xu C, Lin L, Xie Z, Lam MHW, Liang H, Chen X, Eur. J. Pharm. Biopharm., 88, 1086 (2014)
  60. Wang Y, Zhang H, Hao J, Li B, Li M, Xiuwen W, Drug Deliv., 23, 1398 (2016)
  61. Qi SS, Sun JH, Yu HH, Yu SQ, Drug Deliv., 24, 1909 (2017)